Abiopharma

Hlutafjárútboði Alvotech í Bandaríkjunum lokið og umsjónaraðilar nýttu sér að fullu kauprétt á viðbótarbréfum svo heildarandvirði að meðtöldum hlutum keyptum af evrópskum fagfjárfestum nemur 165 milljónum dollara

Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement

Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares

Change in holdings of interested parties/officers

FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Sabino Anthony John

General Announcement: Nomura to Announce First Quarter Operating Results on July 29

VivaTech: With MethaneLive, TotalEnergies Uses Data to Support Methane Emissions Reduction

VivaTech : Avec MethaneLive, TotalEnergies met la Data au service de la lutte contre les émissions de méthane

VivaTech: With MethaneLive, TotalEnergies Uses Data to Support Methane Emissions Reduction

Ericsson appoints David Hammarwall Head of Business Area Networks